The Lancet

The Lancet is a highly respected international journal publishing original research, reviews, and commentary across all medical specialties. It has a strong focus on global health issues and features articles from diverse geographic regions. The site covers various topics including cancer research, mental health, malaria prevention, vaccine development, and long COVID. The site does not show any clear conflicts of interest but occasionally uses dehumanizing language or presents information in a way that could be considered biased or deceptive.

84%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on its reporting.

Bias

90%

Examples:

  • The article uses gender-biased language by highlighting the decrease in combined prevalence of underweight and obesity among women but not men.
  • The author mentions only two specific vaccines for malaria without providing context on other potential options.
  • The Lancet occasionally uses dehumanizing language when referring to certain groups (e.g., people who are overweight or obese, children who die from malaria).

Conflicts of Interest

85%

Examples:

  • The author mentions only two specific vaccines (RTS,S/AS01 and R21/Matrix-M) without providing any context or information about other potential malaria vaccines.
  • There is no clear evidence of conflicts of interest in the articles provided.

Contradictions

85%

Examples:

  • Cameroon has started a routine immunization program against malaria for children, making it the world's first. 'Mosquirix' requires four doses and is about 39% effective.
  • From 1990 to 2022, the combined prevalence of underweight and obesity in adults decreased in 11 countries for women and 17 for men with a posterior probability of at least 0.8.
  • The incidence of at least one antidepressant discontinuation symptom was 0.31 (95% CI 0.27-0.35) in the selected studies.
  • The rate of obesity has more than doubled among adults and increased fourfold among children and adolescents between 1990 and 2022.

Deceptions

75%

Examples:

  • The author uses language that dehumanizes children who die from malaria by referring to them as 'half a million' instead of using more compassionate language.
  • The number of malaria deaths has been declining over the past two decades.

Recent Articles

  • Unraveling the Mystery of Ageing and Cancer: Insights from Recent Research

    Unraveling the Mystery of Ageing and Cancer: Insights from Recent Research

    Broke On: Friday, 05 July 2024 Cancer burden rises, particularly in low-income countries, but advancements in treatment and lifestyle modifications have led to decreased deaths and improved survival rates. Despite this progress, cancer phobia persists due to fear of side effects and prominent cases. Recent studies suggest aging may make cancer less conducive to growth through altered iron metabolism.
  • Antidepressant Discontinuation Symptoms: Prevalence, Impact, and Management

    Antidepressant Discontinuation Symptoms: Prevalence, Impact, and Management

    Broke On: Thursday, 06 June 2024 One in six people may experience antidepressant discontinuation symptoms (ADS) after prolonged use, including anxiety, depression, insomnia, and flu-like symptoms. The exact prevalence and impact of ADS are still debated. Factors increasing the risk include length of use, dosage, and specific antidepressants. Proper tapering under medical supervision can help minimize symptoms.
  • The Alarming Rise of Obesity: A Growing Problem Worldwide

    The Alarming Rise of Obesity: A Growing Problem Worldwide

    Broke On: Friday, 01 March 2024 Obesity is a growing problem worldwide, with more than 1 billion people now living with the condition. The rate of obesity has doubled among women and nearly tripled in men between 1990 and 2022. Niue has the highest prevalence of obesity among women (8.8% to 18.5%) while American Samoa has the highest prevalence among men (4.8% to 14%) for adults.
  • Cameroon Launches Routine Malaria Vaccination Program for Infants, but Convincing Parents to Get Their Children Vaccinated Will Be a Challenge

    Cameroon Launches Routine Malaria Vaccination Program for Infants, but Convincing Parents to Get Their Children Vaccinated Will Be a Challenge

    Broke On: Wednesday, 31 January 2024 Cameroon launches a routine immunization program against malaria for infants, becoming the first country in the world to do so. Despite this breakthrough, convincing parents to have their children vaccinated remains challenging as Mosquirix requires four doses and is only 39% effective.

  • Severity of Initial COVID-19 Symptoms Linked to Long COVID Risk, Study Finds

    Broke On: Monday, 01 May 2023 A study found that those who were bedridden for seven days or more due to initial COVID-19 symptoms were more likely to develop long COVID. Being female, older age, and having five or more symptoms in the first week of illness were also associated with a higher risk of developing long COVID.

  • Study Finds Potential Link Between 'Forever Chemicals' and Thyroid Cancer Risk

    Broke On: Sunday, 15 October 2023 A recent study has found a potential link between per- and polyfluoroalkyl substances (PFAS) and an increased risk of thyroid cancer. The study did not establish a direct cause-and-effect relationship between PFAS exposure and thyroid cancer, and more research is needed to confirm these findings. Other studies have suggested that PFAS may also affect reproductive health.